Reading this on a mobile device? Try our optimized mobile version here:

October 10, 2012
BIO has teamed up with FedEx to offer member companies discounts of up to 35% off select FedEx Express, FedEx Ground and FedEx Home Delivery services through the BIO Business Solutions cost-savings program. Learn more.

The news summaries appearing in BIO SmartBrief are based on original information from news organizations and are produced by SmartBrief, Inc., an independent e-mail newsletter publisher. The information is not compiled or summarized by BIO. Questions and comments should be directed to SmartBrief at

  Today's Top Story 
  • Nobel laureate warns against unproven stem cell treatments
    A growing number of clinics and hospitals worldwide are offering unproven and potentially dangerous stem cell therapies to treat diabetes, multiple sclerosis, Alzheimer's and Parkinson's diseases, spinal cord injuries and other ailments, and Nobel laureate Shinya Yamanaka warned consumers away from these unproven treatments. "If there are no preclinical data in the efficiency and safety of the procedure ... it could be very dangerous," he said. Yamanaka and John Gurdon share this year's Nobel Prize in Medicine for their work on induced pluripotent stem cells. Reuters (10/9) LinkedInFacebookTwitterEmail this Story

With in-depth industry knowledge, GE Capital, Healthcare Financial Services' dedicated Life Science Finance team has worked with more than 500 companies and provided over $2.5 billion in financing to the market. Stop just banking. And start building. Click here to find out more.
  Health Care & Policy 
  • Researchers see promise in use of iPS cells for macular degeneration
    An experimental therapy based on the use of skin cell-derived induced pluripotent stem cells has the potential to treat macular degeneration in people, according to a study published in Molecular Medicine. "With eye diseases, I think we're getting close to a scenario where a patient's own skin cells are used to replace retina cells destroyed by disease or degeneration," said Dr. Stephen Tsang of Columbia University Medical Center. United Press International (10/7) LinkedInFacebookTwitterEmail this Story
  Company & Financial News 
  • Maker of personalized wrinkle therapy pulls in $45M in stock sale
    Fibrocell Science, which developed the first FDA-approved personalized cell therapy for wrinkle reduction, secured $45 million in a private stock sale. The maker of Laviv will use the money to upgrade its production capacity and to develop other applications for the treatment, including as a therapy for burn scars. (10/8) LinkedInFacebookTwitterEmail this Story
  Food & Agriculture 
  • Over 30 newspapers urge Californians to reject biotech labeling law
    More than 30 daily newspapers in California, including the state's largest, have urged their readers to vote "no" on the Proposition 37 biotech labeling law. "Prop 37 could add to food costs for consumers, hurt small businesses and create yet another avenue for costly litigation," according to an editorial in the Santa Cruz Sentinel. (10/9) LinkedInFacebookTwitterEmail this Story
  Industrial & Environmental 
  • Brazilian pulp company to enter biofuels sector
    Brazilian pulp and paper company Fibria Celulose plans to start making biofuels from forestry assets to lessen its reliance on pulp production, which accounted for about 94% of revenue in 2011, CEO Marcelo Castelli said. The company, in partnership with U.S.-based Ensyn Corp., expects to open a wood-to-fuel plant in Brazil in 2015. Bloomberg Businessweek (10/9) LinkedInFacebookTwitterEmail this Story
  News from BIO 
  • Are you taking full advantage of your membership?
    BIO's cost-savings program, BIO Business Solutions, is helping 2,700 companies nationwide save on the cost of essential products and services. Members of BIO and 43 state and regional biotech associations are eligible to receive preferential pricing and other benefits at no additional cost beyond their membership dues. VWR International, FedEx, Office Depot and Business Wire are just a few of the industry leading providers that offer special pricing through this members-only program. Learn more or enroll here. LinkedInFacebookTwitterEmail this Story
Learn more about BIO ->Conferences  |  Join BIO  |  Media  |  Issues  |  Industry

No need to hurry. No need to sparkle. No need to be anyone but oneself."
--Virginia Woolf,
British writer

LinkedInFacebookTwitterEmail this Story

Subscriber Tools
Print friendly format | Web version | Search past news | Archive | Privacy policy

Account Director:  Meryl Harold (202) 407-7828
A powerful website for SmartBrief readers including:
 Recent BIO SmartBrief Issues:   Lead Editor:  Tom Parks
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2012 SmartBrief, Inc.® Legal Information